Accordingly, our results highlight NLGN-2 as a relevant target for future preclinical studies that combine animal models of neurodevelopmental disorders (eg, autism, schizophrenia) with early life stress. The gene discussed is NLGN2; the disease is neurodevelopmental disorder.